Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas

Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas

Detaylı Bibliyografya
Asıl Yazarlar:	Ahmad, M, Catto, J, Azzouzi, A, Cross, S, Feeley, K, Eaton, C, Meuth, M, Hamdy, F, Rehman, I
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2003

Benzer Materyaller

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
Yazar:: Rehman, I, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
Yazar:: Rehman, I, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Tissue microarray immunohistochemistry and cluster analysis confirms the validity of candidate proteins in prostate cancer identified by proteomic analysis of urine
Yazar:: Rehman, I, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

A gene promoter hypermethylation panel to detect transitional cell carcinoma of the bladder
Yazar:: Yates, DR, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Genetic instability and transitional cell carcinoma of the bladder.
Yazar:: Catto, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Calgizzarin (S100A11) immunostaining pattern is altered in prostate cancer suggesting a role in tumourigenesis
Yazar:: Rehman, I, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
Yazar:: Catto, J, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Promoter hypermethylation identifies progression risk in bladder cancer.
Yazar:: Yates, DR, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

The use of proteomics in urological research
Yazar:: Rehman, I, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
Yazar:: Yates, DR, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients
Yazar:: Yates, DR, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
Yazar:: van Oers, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Clinically localised prostate cancer is microsatellite stable.
Yazar:: Azzouzi, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
Yazar:: Catto, J, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Loss of intercellular expression of beta-dystroglycan is a common event in prostate cancer and is significantly associated with loss of differentiation
Yazar:: Cross, S, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis
Yazar:: Carolien M. Woolthuis, ve diğerleri
Baskı/Yayın Bilgisi: (2013-10-01)

Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression
Yazar:: Rehman, I, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression.
Yazar:: Glen, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Phosphorylation-dependent migration of retinoblastoma protein into the nucleolus triggered by binding to nucleophosmin/B23.
Yazar:: Takemura, M, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
Yazar:: Dhawan, D, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Involvement of nucleophosmin (NPM1/B23) in assembly of infectious HPV16 capsids
Yazar:: Patricia M. Day, ve diğerleri
Baskı/Yayın Bilgisi: (2015-12-01)

Development of a prognostic marker panel in bladder cancer using aberrant promoter methylation
Yazar:: Catto, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Aberrant promoter methylation in pre-malignant and invasive tumours of the urinary bladder
Yazar:: Yates, D, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Urinary Bladder Xanthoma – Is Immunohistochemistry Necessary?
Yazar:: M. Raghavendran, ve diğerleri
Baskı/Yayın Bilgisi: (2016-09-01)

DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target
Yazar:: Catto, J, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
Yazar:: Catto, J, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Prostate cancer proteomics: The urgent need for clinically validated biomarkers
Yazar:: Evans, C, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Gli1 appears to be constitutively expressed in the lumenal epithelial cells of the prostate but not in the basal cell layer or the mesenchyme
Yazar:: Spencer, A, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks.
Yazar:: Catto, J, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Nucleophosmin 1 expression in acute myeloid leukemia
Yazar:: Mohammad Davoudi, ve diğerleri
Baskı/Yayın Bilgisi: (2015-10-01)

Nucleophosmin 1 expression in acute myeloid leukemia
Yazar:: Mohammad Davoudi, ve diğerleri
Baskı/Yayın Bilgisi: (2015-09-01)

Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
Yazar:: Rehman, I, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Epigenetic changes in urothelial cancer: A feature of the invasive phenotype and a novel therapeutic target
Yazar:: Catto, J, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
Yazar:: Markéta Šašinková, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
Yazar:: Roupret, M, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation
Yazar:: Duangmano Suwit, ve diğerleri
Baskı/Yayın Bilgisi: (2012-10-01)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
Yazar:: Rouprêt, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
Yazar:: Rehman, I, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Targeting chemotherapy to advanced bladder cancer patients most likely to benefit.
Yazar:: Catto, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
Yazar:: Grzegorz Sarek, ve diğerleri
Baskı/Yayın Bilgisi: (2010-03-01)